IRIS
SFRAMELI, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.024
NA - Nord America 2.726
AS - Asia 1.754
SA - Sud America 722
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 2
Totale 8.281
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.654
RU - Federazione Russa 1.011
SG - Singapore 674
BR - Brasile 646
CN - Cina 563
IE - Irlanda 524
SE - Svezia 307
PL - Polonia 301
DE - Germania 268
IT - Italia 250
HK - Hong Kong 210
VN - Vietnam 105
GB - Regno Unito 101
FI - Finlandia 93
FR - Francia 70
IN - India 63
MX - Messico 41
AR - Argentina 27
CA - Canada 22
TR - Turchia 18
BE - Belgio 16
AT - Austria 14
BD - Bangladesh 14
EC - Ecuador 14
ZA - Sudafrica 14
JP - Giappone 13
UA - Ucraina 13
UZ - Uzbekistan 13
IQ - Iraq 12
NL - Olanda 12
VE - Venezuela 12
ID - Indonesia 10
CZ - Repubblica Ceca 9
MA - Marocco 9
AE - Emirati Arabi Uniti 7
CI - Costa d'Avorio 7
ES - Italia 7
EU - Europa 7
JO - Giordania 7
LT - Lituania 7
PK - Pakistan 7
NP - Nepal 6
PE - Perù 6
KE - Kenya 5
CO - Colombia 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
EG - Egitto 3
IL - Israele 3
KG - Kirghizistan 3
NI - Nicaragua 3
PA - Panama 3
PH - Filippine 3
PY - Paraguay 3
RS - Serbia 3
SA - Arabia Saudita 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
BW - Botswana 1
CH - Svizzera 1
EE - Estonia 1
GY - Guiana 1
JM - Giamaica 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
PS - Palestinian Territory 1
RO - Romania 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.281
Salva come PNG Salva come JPEG
Città #
Dublin 523
Moscow 513
Chandler 425
Ashburn 412
Singapore 337
Dallas 296
Warsaw 294
Beijing 271
Hong Kong 210
Nyköping 198
Princeton 105
The Dalles 92
Ann Arbor 75
Medford 73
Los Angeles 72
Jacksonville 71
Munich 68
Cambridge 57
Messina 54
Des Moines 46
Pune 43
São Paulo 41
Bremen 38
Ho Chi Minh City 36
Boardman 35
Lancaster 35
Buffalo 34
Turku 34
New York 31
Redondo Beach 31
Tianjin 31
Dearborn 30
Houston 27
Shenyang 25
San Mateo 24
Rome 23
Belo Horizonte 21
Jinan 21
Rio de Janeiro 21
Wilmington 20
Nanjing 17
Nürnberg 17
Brasília 16
Brussels 16
Hanoi 16
Dong Ket 15
Frankfurt am Main 15
Hebei 15
Porto Alegre 14
Ningbo 13
Poplar 13
Tashkent 13
Tokyo 13
Mexico City 12
Atlanta 11
Curitiba 11
Hangzhou 11
Zhengzhou 10
Campinas 9
Guadalupe 9
Haikou 9
Johannesburg 9
Seattle 9
Stockholm 9
Taizhou 9
Chicago 8
Falls Church 8
Nuremberg 8
Toronto 8
Abidjan 7
Amman 7
Baghdad 7
Brooklyn 7
Helsinki 7
Jakarta 7
Montreal 7
Palo Del Colle 7
Phoenix 7
Santa Clara 7
São Bernardo do Campo 7
Amsterdam 6
Ankara 6
Boston 6
Cagliari 6
Catania 6
Changsha 6
Charlotte 6
Chennai 6
Denver 6
Goiânia 6
Jiaxing 6
Osasco 6
Salvador 6
Vienna 6
Brno 5
Carapicuíba 5
Ciudad Benito Juárez 5
Council Bluffs 5
Guangzhou 5
Guarulhos 5
Totale 5.327
Salva come PNG Salva come JPEG
Nome #
Severe rhabdomyolysis in a patient with “Heat Stroke” 250
Clinical and molecular characterization of patients affected by congenital muscular dystrophies using next generation sequencing strategies 241
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 180
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 156
Autonomic nervous system involvement in spinal muscular atrophy. 145
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 143
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 143
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 139
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 139
Effect of exercise on telomere length and telomere proteins expression in mdx mice 133
Nusinersen versus sham control in later-onset spinal muscular atrophy 133
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 128
Pilot study of serial casting in muscular dystrophy patients. 127
Pilot study of serial casting of ankles in muscular dystrophy patients. 126
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 125
Pilot study of flavocoxid in ambulant DMD patients. 125
The 24-month PUL changes and steroids correlation. 125
An observational study of functional abilities in infants, children, and adults with type 1 SMA 125
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 124
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 123
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 119
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 117
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 117
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 116
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 116
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 115
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 115
Psychosocial impact of sport activity in neuromuscular disorders 113
Pilot study of flavocoxid in ambulant DMD patients. 112
Severe rhabdomyolysis in a patient with “Heat Stroke” 112
Pilot study of flavocoxid in ambulant DMD patients. 111
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 110
Development of an academic disease registry for spinal muscular atrophy 110
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 108
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 108
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 108
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 107
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data 107
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with neuromuscolar disorders: a speckle tracking study 106
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 106
Burden, social network and professional support in the families of patients with muscular dystrophies: results from the GUP10002 study. 104
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy 103
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with Duchenne muscular dystrophy: a skeckle tracking study. 102
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 101
Clinical variability in spinal muscular atrophy type III 101
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies in the UK and differences with the Italian population 100
study of flavocoxid in ambulant DMD patients. 99
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 99
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 95
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 94
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies: Analysis of the UK diagnostic service 2001-2013. 94
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 92
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey? 90
The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys 89
Pilot study of flavocoxid in ambulant DMD patients. 89
Congenital myastenic syndromes due a novel GFPT1 mutation: a new Italian case 85
The first report of a patient carrying an out-of-frame exon2 deletion in the dystrophin gene and showing a very unusual phenotype. 84
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 81
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study 77
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies 74
Stato dell'arte sulle terapie della Distrofia muscolare di Duchenne. 74
Old measures and new scores in spinal muscular atrophy patients 73
The respiratory symptom check-list for patients with myotonic dystrophies: preliminary results. 73
Neuropsychiatric comorbidities in Duchenne Muscular Dystrophy. 70
The first report of a patient carrying an out-of-frame exon2 deletion in the dystrophin gene and showing a very unusual phenotype. 69
Pilot study of flavocoxid in ambulant DMD patients. 69
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 66
The families of children with muscular dystrophies: burden, social network and professional support. 63
“I have got something positive out of this situation”: Psychological benefits of caregiving in relatives of young people with muscular dystrophy 62
Sleep disorders in spinal muscular atrophy 61
Nusinersen in type 1 SMA infants, children and young adults: Preliminary results on motor function 60
Body mass index in type 2 spinal muscular atrophy: a longitudinal study 59
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. 59
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 55
The genetic spectrum of a large cohort of putative CMD. 55
Molecular analysis of SMARD1 patient-derived cells demonstrates that nonsense-mediated mRNA decay is impaired 52
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life Inventory TM neuromuscular Module in the Italian population and correlation with other functional assessments. 51
Screening for early symptoms of respiratory involvement in myotonic dystrophy type 1 using the Respicheck questionnaire 51
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy 50
Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with Nusinersen 49
The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measure 49
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 38
null 27
null 22
null 20
null 20
null 18
null 15
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar function 14
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 14
Totale 8.474
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.051
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 18 39 18 18 36 9 21
2021/2022499 3 43 5 34 24 4 45 19 8 57 39 218
2022/20231.458 99 149 69 107 131 128 10 71 649 9 29 7
2023/2024377 17 63 18 53 25 98 33 15 0 6 5 44
2024/20251.796 39 35 38 111 57 51 66 374 405 133 183 304
2025/20262.834 274 334 356 375 458 1.037 0 0 0 0 0 0
Totale 8.474